Instuitional Investor - Regeneron Pharmaceuticals, Inc.

Fund Profile
Filing Period:
Fund Name: Regeneron Pharmaceuticals, Inc.
Portfolio Value $177,219,142
Filing Period:
No. Security Ticker Shares Value % Port
1.
Parabilis Medicines Inc.
4,166,666 $114,041,648 64.35%
2. NTLA 3,702,995 $62,654,675 35.35%
3. ACET 60,511 $522,819 0.3%
4. ACET 0 $0 0%